Physician profile

Catherine Majcher

Adult Health (Nurse Practitioner) · Niles, IL

NPI 1861864175

$3,803.12

in general payments reported to CMS, 2019-2025

36 companies · $916 in 2025

The $916 reported for 2025 was more than what 83% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).

See the full distribution for Adult Health (Nurse Practitioner)

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$1,700.38
Education$384.97

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Novartis Pharmaceuticals Corporation $835.55 2021-2025
Astellas Pharma US INC $410.57 2022-2025 Xospata, Vyloy
Abbvie INC. $303.26 2021-2025
Incyte Corporation $294.90 2021-2025 Jakafi
Pharmacyclics LLC, An Abbvie Company $210.33 2021-2022
Gilead Sciences, INC. $175.88 2022-2025 Trodelvy
Seagen INC. $160.98 2021-2025
Lilly USA, LLC $152.85 2021-2023 Verzenio
Janssen Biotech, INC. $107.22 2021-2025 Tecvayli, Darzalex, Carvykti
Takeda Pharmaceuticals U.S.A., INC. $98.85 2023-2025 Iclusig
E.R. Squibb & Sons, L.L.C. $97.60 2023-2025 Opdivo
Pfizer INC. $94.96 2021-2025
Amgen INC. $86.20 2021-2022
Genzyme Corporation $82.47 2021-2025
Merck Sharp & Dohme LLC $75.63 2021-2022
Show all 36 companies
CompanyGeneral paymentsYearsTop products
Glaxosmithkline, LLC. $68.15 2023-2025 Jemperli, Zejula
Agios Pharmaceuticals, INC. $61.04 2025 Pyrukynd
Daiichi Sankyo INC. $50.79 2021-2025 Vanflyta
Beigene USA, INC. $36.32 2021
Pharmaessentia USA Corporation $35.69 2025 Besremi
Tersera Therapeutics LLC $32.06 2025 Zoladex
Astrazeneca Pharmaceuticals LP $29.88 2024 Imfinzi
Karyopharm Therapeutics INC. $24.82 2022
Emd Serono, INC. $23.45 2025
Eisai INC. $23.34 2023
Geron Corporation $23.04 2025 Rytelo
Servier Pharmaceuticals LLC $22.92 2025
G1 Therapeutics, INC. $22.53 2022
Fennec Pharmaceuticals, INC. $22.45 2024 Pedmark
Deciphera Pharmaceuticals INC. $22.41 2021
Genentech USA, INC. $21.28 2023 Tecentriq
Morphosys, US INC. $21.02 2022
Mirati Therapeutics, INC. $21.00 2023 Krazati
Puma Biotechnology, INC. $20.61 2025
Sobi, INC $19.31 2025
Melinta Therapeutics, LLC $13.76 2024 Rezzayo

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Catherine Majcher

$3,803.12

in general payments reported 2019-2025

Years
2021-2025
Top company
Novartis Pharmaceuticals Corporation
Context
The $916 reported for 2025 was more than what 83% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).

https://glasscript.com/doctor/11028931/catherine-majcher

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.